SEC Form 4 Reporting Owner · CIK 0001383838
Shah Capital Management
Chair at Emeren Group Ltd
Bought (12 mo)
—
Sold (12 mo)
—
Form 4 Filings
26
Companies
1
Filing Activity
2024-12-20
first filed 2021-06-24
Trading record
Open-market buys
+$14M
25 filings
Open-market sales
—
0 filings
Sales under a 10b5-1 plan
—
No open-market sales
Companies
| Company | Role | Filings | Bought | Sold | Net | Holding after latest filing |
|---|---|---|---|---|---|---|
| SOLEmeren Insider trading | Chair | 26 | 4,195,321 | — | +4,195,321 | 18,818,236 2024-12-20 |
Common-stock shares bought and sold on the open market, as reported on Form 4. The holding is what the latest filing at each company reported owning after its transactions.
Also files as
13F Institutional investment manager · SHAH CAPITAL MANAGEMENT 13F holdings
13D/G Beneficial owner of 5% or more · 2 open stakes (3 reported closed)
| Company | Schedule | % of class | Filed |
|---|---|---|---|
| Novavax | 13D | 6.5% | 2026-10-16 |
| VEON | 13D | 6.7% | 2026-10-16 |